These innovative therapies, including Semaglutide , belong to a class of drugs called GLP-1 receptor agonists . Primarily developed for managing high blood sugar, they work by encouraging the organism to release adequate insulin and reducing excessive sugar levels. Additionally , their potential to support weight loss has contributed to significant